Lab Tests Directory
Browse our comprehensive catalog of medical tests. Book online and get tested at home or at any of our partner labs across all 7 Emirates.
Oncomine Myeloid DNA Panel
This blood test specifically analyzes your DNA for genetic mutations frequently found in myeloid disorders, which are conditions affecting the production of certain blood cells. It provides insights into the underlying genetic causes of these conditions.
Oncomine Myeloid RNA Panel
This blood test focuses on analyzing your RNA for specific gene fusions and expressions related to myeloid disorders. These RNA changes can indicate the presence of certain blood cancers or conditions affecting blood cell production.
Oncomine myeloproliferative neoplasm (MPN) panel
This panel analyzes specific genes associated with myeloproliferative neoplasms (MPNs), a group of blood cancers where the bone marrow produces too many blood cells. It helps identify genetic mutations that drive these conditions, guiding diagnosis and treatment decisions.
OncoMonitor ® TRM (Liquid biopsy) Liquid Biopsy Test for Longitudinal Cancer Monitoring
This advanced liquid biopsy test is designed for ongoing monitoring of cancer progression and treatment response over time. It analyzes circulating tumor DNA from a blood sample to track changes in your cancer.
OncoMonitor MRD (Liquid biopsy) For MRD Detection
This liquid biopsy test helps detect very small amounts of cancer cells that might remain in the body after treatment, known as Minimal Residual Disease (MRD). It uses a simple blood sample to look for cancer DNA circulating in your bloodstream.
OncoTarget TBx (Tissue Biopsy)
This advanced test uses a blood sample to provide comprehensive genetic profiling of your cancer. It helps identify specific mutations and biomarkers that can guide personalized treatment decisions, offering insights similar to a tissue biopsy but with a less invasive approach.
OncoTarget® LBx (Liquid biopsy) Tailored NGS Panel for Solid Tumors
This advanced liquid biopsy test analyzes DNA fragments released by solid tumors into your bloodstream. It offers a non-invasive way to understand the genetic makeup of your cancer, providing crucial insights without the need for a traditional tissue biopsy.
OncoTarget® TBx + PDL-1 (Dako 22C3) (Tissue biopsy) Tailored NGS Panel for Solid Tumors
This comprehensive test analyzes a tissue biopsy to provide a tailored Next-Generation Sequencing (NGS) panel for solid tumors, including PDL-1 expression. It identifies specific genetic alterations and protein markers to guide personalized treatment strategies.
OncoTarget® TBx + PDL-1 (Ventana) (Tissue biopsy) Tailored NGS Panel for Solid Tumors
This comprehensive test analyzes a tissue biopsy to provide a tailored Next-Generation Sequencing (NGS) panel for solid tumors, including PDL-1 expression. It identifies specific genetic alterations and protein markers to guide personalized treatment strategies.
Oncotype Dx Breast Cancer
The Oncotype Dx Breast Cancer test analyzes specific genes in breast tumor tissue to predict the likelihood of cancer recurrence and the potential benefit of chemotherapy. It provides a personalized recurrence score to guide treatment decisions.
Osteocalcin BGP-Bone Gla Protein
The Osteocalcin BGP test measures the levels of osteocalcin, a protein produced by bone-forming cells (osteoblasts). It serves as a specific marker for bone formation and turnover in your body.
Osteogenesis imperfecta gene panel
The Osteogenesis Imperfecta gene panel is a genetic test that analyzes multiple genes associated with "brittle bone disease." It identifies specific mutations that can cause bones to break easily.